HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status (Q40673772)

22 September 2017

title

HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status (English)

1 reference

22 September 2017

author

Marly Augusto Cardoso

object named as

Marly Augusto Cardoso

7

0 references

Eduardo L. Franco

object named as

Eduardo L Franco

9

0 references

Adhemar Longatto-Filho

object named as

Adhemar Longatto-Filho

6

0 references

author name string

Lyndsay Ann Richardson

1

1 reference

22 September 2017

Mariam El-Zein

2

1 reference

22 September 2017

Agnihotram V Ramanakumar

3

1 reference

22 September 2017

Samuel Ratnam

4

1 reference

22 September 2017

Ghislain Sangwa-Lugoma

5

1 reference

22 September 2017

Francois Coutlée

8

1 reference

22 September 2017

PEACHS (Pap Efficacy After Cervical HPV Status) Study Consortium

10

1 reference

22 September 2017

publication date

31 July 2015

1 reference

22 September 2017

1 reference

22 September 2017

volume

123

1 reference

22 September 2017

issue

12

1 reference

22 September 2017

page(s)

745-754

1 reference

The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Effect of type-specific human papillomavirus incidence on screening performance and cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Prior knowledge of HPV status improves detection of CIN2+ by cytology screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Visual inspection as a cervical cancer screening method in a primary health care setting in Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Diet and serum micronutrients in relation to cervical neoplasia and cancer among low-income Brazilian women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Associations of dietary dark-green and deep-yellow vegetables and fruits with cervical intraepithelial neoplasia: modification by smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Polymorphisms in genes involved in folate metabolism modify the association of dietary and circulating folate and vitamin B-6 with cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

The 2001 Bethesda System: terminology for reporting results of cervical cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Bias, prevalence and kappa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Correcting for partial verification bias: a comparison of methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Assessment of diagnostic tests when disease verification is subject to selection bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Sensitivity and specificity of a single diagnostic test in the presence of work-up bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Estimates of sensitivity and specificity can be biased when reporting the results of the second test in a screening trial conducted in series

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

A randomized controlled trial of Human Papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

HPV testing with cytology triage for cervical cancer screening in routine practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

The clinical impact of using p16(INK4a) immunochemistry in cervical histopathology and cytology: an update of recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

inferred from DOI database lookup

7 January 2021

based on heuristic

The impact of new technologies in cervical cancer screening: results of the recruitment phase of a large randomised controlled trial from a public health perspective

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21596

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCY.21596

1 reference

22 September 2017

1 reference